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PoreThe sphingolipid, ceramide, self-assembles in the mitochondrial outer membrane (MOM), forming large
channels capable of translocating proteins. These channels are believed to be involved in protein release
from mitochondria, a key decision-making step in cell death. Synthetic analogs of ceramide, bearing modiﬁ-
cations in each of the major structural features of ceramide were used to probe the molecular basis for the
stability of ceramide channels. Channel stability and mitochondrial permeabilization were disrupted by
methylation of the C1-hydroxyl group whereas modiﬁcations of the C3 allylic hydroxyl group were well tol-
erated. A change in chirality at C2 that would inﬂuence the orientation of the C1-hydroxyl group resulted in a
strong reduction of channel-forming ability. Similarly, methylation of the amide nitrogen is also detrimental
to channel formation. Many changes in the degree, location and nature of the unsaturation of ceramide had
little effect on mitochondrial permeabilization. Competition experiments between ceramide and analogs
resulted in synergy with structures compatible with the ceramide channel model and antagonism with in-
compatible structures. The results are consistent with ceramide channels being highly organized structures,
stabilized by speciﬁc inter-molecular interactions, similar to the interactions responsible for protein folding.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The sphingolipid, ceramide, has been shown to be able to form
channels in planar membranes [1], liposomes [2] and the mitochon-
drial outer membrane [3,4]. In mammalianmitochondria, channel for-
mation occurs at physiologically relevant ceramide levels [4]; levels
measured in mitochondria from cells early in the apoptotic process
[5–7]. In addition, the propensity to form channels and their size is
inﬂuenced by Bcl-2 family proteins [8,9]. These channels are large,
stable and capable of allowing proteins to cross membranes [3,4].
The size was determined from the molecular weight of proteins re-
leased frommitochondria [3], from the conductance of single channels
formed in planar membranes [10], and from visualization of the pores
by electron microscopy [11]. A range of sizes was reported with a typ-
ical channel having an estimated pore diameter of 10 nm [10,11]. Thuser, D-e-C8-ceramide; C16-Cer,
2,4-dinitrophenol; BSA, fatty
ndrial outer membrane; DPX,
niversity of Maryland, College
301 314 9358.
.
rights reserved.hundreds of ceramidemoleculesmust spontaneously self-assemble in
the 2-dimensional liquid phase of the membrane. Unlike the ﬂuid and
transient toroidal pores or lipidic pores formed when lamellar lipids
are disturbed by amphipathic molecules such as peptides or synthetic
structures [12–14], whole proteins [15,16], or at the phase transition
[17], the channels formed by ceramide seem to be highly structured
and rigid. The disassembly of channels formed by short-chain cer-
amide shows a quantization of conductance with a strong preference
for large conductance drops to be multiples of 4 nS [10]. This ﬁnding
not only supports the notion that ceramide channels are highly-
organized cylindrical structures, but is also consistent with amodiﬁca-
tion of the originally-proposed barrel-stave structure [1]. Each stave of
the barrel is proposed to consist of a stack of ceramide molecules held
together by intermolecular hydrogen-bonding through the amide and
carbonyl groups of the amide linkage. These span the membrane
forming a cylinder when arranged in an anti-parallel fashion (supple-
mental Fig. 1S) [10]. Molecular dynamic simulations indicate that this
structure is stable [18].
The ability of ceramide to form channels must, at least in part, be
attributed to the structural features of the ceramide molecule. The
polar head group of ceramide (Fig. 1), with its amide linkage and
two hydroxyl groups located in close proximity, constitutes a triden-
tate hydrogen-bonding donor/acceptor center and is capable of
Fig. 1. Structure of N-palmitoyl-D-erythro-sphingosine (D-e-C16-ceramide or C16-Cer) showing the major features of the molecule and the codes used for the synthetic analogs: H for
changes to the hydroxyl groups, S for changes in stereochemistry, A for changes to the amide group, T for changes to the trans double bond and L for changes to the chain length.
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actions. These structural features may partly explain its ability to
form large, stable channels in membranes. However, it is not known
if the location and orientation of the interacting groups are critical
to achieve a stable structure. In addition, other structural features
(such as the length of the hydrocarbon chains and the number and
conﬁguration of the double bonds) may be important. Therefore, we
have undertaken a study of synthetic ceramide analogs (Table 1,
Fig. 2) to determine (a) if naturally occurring ceramides are uniquely
suited to form large aqueous pores and (b) the structural and stereo-
chemical features in ceramide that are necessary for the formation of
large channels.2. Materials and methods
2.1. Reagents
N-Palmitoyl-D-erythro-sphingosine (D-e-C16-ceramide or C16-Cer)
and N-oleoyl-D-erythro-sphingosine (D-e-C18:1-ceramide or C18:1-
Cer) were obtained from Avanti Polar Lipids (Alabaster, AL). The ana-
logs of C16-Cer and D-e-C8-ceramide (C8-Cer) and {T1, T4} (Fig. 2)
were synthesized as described previously [19–26]. Antimycin A, 2,4-
dinitrophenol (DNP), horse heart cytochrome c, and fatty acid depleted
bovine serum albumin (BSA) were purchased from Sigma (St. Louis,
MO). DPX (p-xylene-bis-pyridinium bromide) was purchased from
Molecular Probes (Invitrogen). 5(6)-carboxyﬂuorescein was purchased
from Acros Organics.Fig. 2. Chemical structures of the analogs used.2.2. Preparation of rat liver mitochondria
Rat liver mitochondria were isolated by differential centrifuga-
tion of tissue homogenates as described previously [27] as modiﬁed
[3]. Brieﬂy, male Sprague–Dawley rats were fasted overnight and
sacriﬁced by decapitation. The liver was excised and minced in
cold isolation medium, H buffer (70 mM sucrose, 210 mM mannitol,
0.1 mM EGTA, 5.0 mM HEPES, pH 7.5), supplemented with 0.5%
(w/v) fatty-acid depleted BSA followed by homogenization in a mo-
torized Potter–Thomas Teﬂon-glass homogenizer (two passes). The
homogenate was subjected to 10-min cycles of low speed (600g)
and high speed (8600g) centrifugations in the same medium
(twice each) at 4 °C in a Sorvall SS-34 rotor. After the low speed
spin, the supernatant was collected and spun at high speed. The pel-
let obtained after the high speed centrifugation was resuspended in
the medium of the same composition and centrifuged. BSA was re-
moved by centrifugation at 8600g in BSA-free medium. The ﬁnal mi-
tochondrial pellet was resuspended in an ice cold sucrose free
isotonic buffer FH (280 mM mannitol, 0.1 mM EGTA, 2 mM HEPES,
pH 7.4). The mitochondrial intactness was determined from the
rate of cytochrome c oxidation (vide infra) compared with the rate
measured after mild hypotonic shock [28].
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Horse heart cytochrome c (2 mM) was reduced by an excess of
reducing agent, ascorbate (40 mM), 0.2 M Tris-Cl (pH 7.5). The re-
duced cytochrome cwas separated from ascorbate by using Sephadex
G-10 gel ﬁltration [3]. The concentration of reduced cytochrome c
was determined spectrophotometrically from the absorbance at
550 nm.
2.4. Cytochrome c oxidation assay as a measure of mitochondrial outer
membrane permeability
The rate of oxidation of exogenously-added reduced cytochrome c
by cytochromeoxidase in isolatedmitochondria is ameasure of the per-
meability of the outermembrane to cytochrome c because translocation
of cytochrome c through the outermembrane is a rate limiting step (see
Fig. 2S). The procedure previously described [29] was modiﬁed to im-
prove reproducibility. As the mitochondria were found to be more sta-
ble at higher concentrations, mitochondria were diluted in H buffer at
4 °C to a concentration of 0.2 mg/mL, in small batches just before the
assay. Then, 50 μL aliquots were dispersed in 650 μL of room tempera-
ture H buffer supplemented with 5 mM DNP and 5 μM antimycin A.
The ﬁnal protein concentration was 14.3 μg/mL. The mitochondria
were allowed to acclimate at room temperature (10 min) in amicrofuge
tube. Then ceramide or one of the analogs (dissolved in 2-propanol at
1 mg/mL) was delivered to the mitochondria while the suspension
was vortexed for 30 s to achieve effective dispersal of the sphingolipid.
After dispersal, the mixture was incubated for 10 min at room temper-
ature followed by addition of cytochrome c (20 μL; ﬁnal concentration,
approx. 25 μM) and immediate measurement of the absorbance
at 550 nm for a period of 2 min. The initial rate of decline of absorbance
of reduced cytochrome cwas used as a measure the permeability of the
outer membrane to cytochrome c; ε550 (red-ox)=18.5 mM−1 cm−1.
Vehicle controls were treated in an identical way. The percent of mito-
chondria with intact MOMs in these experiments was greater thanTable 1
Ceramide analogs.
Code Structural change Type/location of
change
S1 enantiomer: 2S,3R to 2R,3S Stereochemical
S2 diastereomer: 3R to 3S
A1 C16-ceramine (conversion of amide chain
to amine-linked chain)
amide linkage
A2 C8-ceramine
A3 N-methylation of amide chain
A4 urea-ceramide
A5 α-methoxy group in amide chain of
C8-ceramide
H1 O-methylation of C1-hydroxyl group hydroxyl group
H2 O-methylation of C3-hydroxyl group
H3 oxidation of C3-OH to keto group; no double bond
T1 translocation of double bond on sphingoid base trans double bond
T2 phytoceramide: double bond replaced by OH
at C4
T3 double bond converted to triple bond
T4 allene: adjacent double bonds
T5 4,6-diene: conjugated trans double bonds in
C8-ceramide
T6 trans double bond converted to cis in C8-ceramide
T7 translocation of double bond and C3-OH in
C8-ceramide
L1 C10-ceramide hydrocarbon chains
L2 truncation of sphingoid base
L3 C8-ceramide
L4 NBD-ceramide
L5 N-palmitoyl-serinol
L6 N-oleoyl-ceramide (C18:1)85%. Rates were corrected for the rate of oxidation observed with
vehicle alone and this was very close to the untreated rate arising
from a small number of damaged mitochondria.
The sensitivity of isolated mitochondria to permeabilization by
added ceramide or analogs varied from one preparation to another.
Therefore experiments with analogs were always performed in paral-
lel with experiments with C16-Cer. In this way the permeabilization
produced by the analog (measures as the rate of cytochrome c oxida-
tion) could be compared to that of C16-Cer, either directly by report-
ing both rates or by expressing the result as a percent of that
observed with C16-Cer (Table 2).
The degree of cooperativity between an analog and C16-Cer was
determined by averaging the rate of cytochrome c oxidation achieved
with a speciﬁc amount of each agent alone (called the “expected
average”) and comparing this with the rate observed with half the
amount of each agent added combined (called the “combined effect”).
The degree of cooperativity is expressed as the ratio of the combined
effect to the expected average. A result not signiﬁcantly different from
“1”means no cooperativity; greater than “1” is synergy; less than “1” is
antagonism.
2.5. Measurement of adenylate kinase release
The assay was performed as described earlier [30]. Mitochondrial
suspensions containing 160 μg of mitochondrial protein were resus-
pended in isotonic buffer to a ﬁnal volume of 1 mL. After the mito-
chondria were acclimated at room temperature for 10 min,
ceramide or the analog was added, while vortexing. Themitochondria
were incubated for 10 min at room temperature followed by centrifu-
gation (14,000g) for 5 min at 4 °C (Beckman Coulter Microfuge 22R
Centrifuge). A portion of the supernatant (300 μL) was combined
with adenylate kinase reaction mixture (700 μL; 50 mM Tris, 5 mM
MgSO4, 10 mM glucose, 5 mM ADP, 0.2 mM NADP, pH 7.5) that had
been preincubated for 2 min with enzyme mixture (5 μL; 2.5 units
of hexokinase and 8.7 units of glucose 6-phosphate dehydrogenase)
to consume ATP present in the reaction mixture prior to addition of
the supernatant. The absorbance increase at 340 nm, from the gener-
ation of NADPH, was measured over 2 min. The maximal release was
determined by measuring the activity of the supernatant obtained
from an equal amount of osmotically shocked mitochondria. Mea-
surement of adenylate kinase release does not measure the mito-
chondrial outer membrane (MOM) permeability but rather detects
that, at some point after treatment, the MOM was made permeable
(perhaps transiently) to this 26 kDa protein.
2.6. Measurement of lipid insertion into mitochondria
C16-Cer, one of the analogs, or a combination of both was added to
a 0.7 mL mitochondrial suspension containing 160 μg of mitochon-
drial protein in H buffer. In each experiment 30 μL of a 1 mg/mL 2-
propanol solution of the lipid(s) was added while vortexing as de-
scribed above. The suspension was then layered on 0.7 mL of ice-cold
solution of 15% (w/v) sucrose, 5 mM HEPES pH 7.5 and centrifuged at
18,000g for 5 min at 4 °C. (Beckman Coulter Microfuge 22R Centrifuge).
Themitochondria pelleted and the uninserted lipid remained out of the
sucrose layer. (Prior experiments showed that dispersed ceramide
ﬂoats at this density [11]) Most of the supernatant was aspirated
gradually and the tube inverted and any liquid wiped off with
paper wiper. The pellets were used for lipid extraction and measure-
ment of the mitochondria incorporated ceramide and analogs by
LC-MS/MS as previously described [31,32].
2.7. Liposome permeabilization
Single-walled liposomes (93% asolectin and 7% cholesterol, by
weight) were prepared by the extrusion method as previously
Table 2
Relative potency of analogs to permeabilize the mitochondrial outer membrane. MOM was permeabilized by the addition of the indicated amount of analog (nmoles of analog
per μg of mitochondrial protein) and the degree of permeabilization, as measured by the rate of cytochrome c oxidation is expressed as a percent (± S.E. of at least 3 trials) of
the permeabilization measured in parallel experiments with C16-Cer. The P values indicate the statistical signiﬁcance of the permeabilization compared to that observed with
C16-Cer using the Student's t test. N/D means not done. N/S means not signiﬁcantly different at the 95% conﬁdence level.
Compound Code % of C16-Cer permeabilization
at 0.5–1 nmol/μg protein
P value % of C16-Cer permeabilization
at 3 nmol/μg protein
P value % of C16-Cer partitioning
from Table 3
(2R,3S,4E) C16-ceramide S1 No effect (P=0.32 relative to vehicle control) b0.01 16±4 b0.01 40
(2S,3S,4E) C16-ceramide S2 40±60 N/S 80±9 b0.05 –
(2S,3R,4E) N-methyl-C16-ceramide A3 No effect (P=0.41 relative to vehicle control) b0.02 21±4 b0.01 75
(2S,3R,4E) C16-urea-ceramide A4 236±35 N/S 229±7 b0.005 –
(2S,3R,4E) 3-O-methyl-C16-ceramide H2 125±3 N/S 107±15 N/S 60
(2S)-3-keto-C16-dh-ceramide H3 N/D 320±82 b0.01 –
(2S,3R,15E) C16-dh-ceramide T1 76±4 b0.03 385±59 b0.001 30
(2S,3R,4R) C16-phytoceramide T2 429±27 b0.03 230±50 b0.05 460
(2S,3R) C16-4,5-tb-ceramide T3 N/D 120±20 N/S –
(2S,3R,4E) C16-(4,5-allene)-ceramide T4 N/D 303±26 b0.02 –
(2S,3R,4E) C10-ceramide L1 46±17 b0.02 662±26 b0.005 90
(2S,3R,4E) 13C/C16-ceramide L2 1310±104 b0.005 606±27 b0.005 –
N-palmitoyl-serinol L5 N/D 306±92 b0.01 –
(2S,3R,4E)C18:1-ceramide L6 100±19 N/S 113±4 N/S –
Fig. 3. Examples of dose–response curves of the analogs used. The cytochrome c oxidation
rate was used to assess the permeability of the MOM to proteins. The indicated amount of
analog was added to 0.7 mL of a mitochondrial suspension (see Section 2.4).
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a buffer containing 1.5 mM carboxyﬂuorescein (CF), 6 mM DPX,
38.8 mM NaCl, 10 mM HEPES, and 1 mM EDTA, pH 7.0. The mixture
was vortexed and subjected to 4 cycles of freeze–thaw-sonication fol-
lowed by freeze–thawing and extrusion through a polycarbonate
membrane (13 times) to form uniform single walled vesicles
(100 nm diameter). A Sephacryl S200 gel ﬁltration column
(1.5 cm×30 cm) was used to separate the liposomes from untrapped
ﬂuorophore using an isoosmotic elution buffer lacking carboxyﬂuor-
escein and DPX (50 mMNaCl, 10 mMHEPES, 1 mM EDTA, pH 7.0). Al-
iquots (100 μL; containing approximately 0.1 mg of lipid) of the
liposome suspension were diluted into 2 mL of the eluting buffer. CF
was excited at 495 nm and the emitted light was detected at
520 nm in a Deltascan spectroﬂuorometer (Photon Technology In-
struments). The ﬂuorescence intensity was measured as a function
of time under constant stirring and the test compound was added.
The increase in ﬂuorescence intensity was the result of the release
of CF from the liposomes and its dilution from the quenching agent,
DPX. The maximal increase in ﬂuorescence intensity was measured
after the addition of 150 μL of 5% Triton-X 100. The liposome perme-
abilization was plotted as % release of CF relative to maximal release.
2.8. Channel formation in planar membranes
Electrophysiological studies were conducted on some of the ana-
logs to determine whether they were able to permeabilize planar
phospholipid membranes devoid of proteins or other mitochondrial
factors. Planar phospholipid membranes were generated using the
monolayer method as previously described [33] and modiﬁed [34].
The lipids comprising the monolayers were 1,2-diphytanoyl-sn-gly-
cero-3-phosphocholine, asolectin, and cholesterol at a 1:1:0.1 ratio
by weight. The aqueous solutions were 1.0 M KCl, 1 mM MgCl2,
5 mM PIPES pH 6.9 on both sides of the chamber. The bilayer was
formed across a 100 μm diameter hole in a Saran partition. Calomel
electrodes were used to interface with the aqueous solution, the volt-
age was clamped and the current recorded. To form a channel, succes-
sive additions of 5–20 μL of 0.05 mg/mL of the analog in 2-propyl
alcohol were stirred into the aqueous solution (5 mL) on one side of
the membrane. The vehicle has no effect and its ﬁnal concentration
was less that 1% (v/v).
3. Results
The analogs were tested for their ability to permeabilize the outer
membrane of isolated rat liver mitochondria to proteins, using the
cytochrome c oxidation assay (Fig. 2S). Permeation through theMOM limits the rate of oxidation of exogenously-added cytochrome
c by cytochrome oxidase in the inner membrane and thus the initial
rate of oxidation cytochrome c was utilized as a measure of the per-
meabilization of the MOM to proteins. Sample dose–response curves
are shown in Fig. 3. Note that the shapes of these curves vary from
rectangular hyperbola to sigmoid, making rigorous comparisons difﬁ-
cult. Generally a dose of 30 nmol per 10 μg of mitochondrial protein
was chosen as the common dose for comparison because it was low
enough to avoid pronounced saturation by some analogs but high
enough to detect permeabilization by the less-effective analogs.
Results with lower doses are also reported. The sensitivity of mito-
chondria to MOM permeabilization varied from one isolation to the
next so the permeabilization results summarized in Table 2 are
expressed as a percentage of the permeabilization achieved by
ceramide in the same mitochondrial preparation, either C16-Cer
or C8-Cer, as appropriate.
An indication of MOM permeabilization was also obtained by
measuring the extent of release of adenylate kinase. This is not a mea-
sure of MOM permeabilization but rather an indication of the fraction
of mitochondria that have been permeabilized. With one notable out-
lier (vide infra) the MOM permeabilization assay and the adenylate
kinase release assay yielded similar results for the analogs when com-
pared to the effect of ceramide (Fig. 4). The permeabilizing ability of
the analog is expressed as a fraction of the ability of the correspond-
ing ceramide, either C16-Cer or C8-Cer. The line drawn is not ﬁt to the
Fig. 4. Correlation between changes in MOM permeability and adenylate kinase release
by analogs. The “permeabilization relative to ceramide” is the rate of cytochrome c
oxidation induced by the analog divided by that induced by ceramide (C16-Cer for
triangles and C8-Cer for inverted triangles) under the same conditions. “adenylate
kinase release relative to ceramide” is the activity of adenylate kinase released
from mitochondria by analog addition divided by that released by ceramide. The error
bars are standard error of at least three experiments.
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experimental results.
The MOM permeabilization is dependent on the extent of inser-
tion of the analog into the mitochondria, the propensity for channel
formation, and the stability of the channels. Typically, only 0.3% to
1% of the added analog actually inserted into the mitochondrial mem-
branes (Table 3). Phytoceramide was the exception with nearly 5%
insertion. The extent of insertion helped to interpret the observed
ability of an analog to permeabilize the MOM.3.1. Ability of analogs to permeabilize the MOM to proteins
Changes in the non-polar portions of ceramide did not interfere
with channel formation. The analogs of ceramide having a shorter
N-acyl chain {L1} or a shorter sphingosine backbone {L2, L5} were
more potent in permeabilizing the MOM than C16-Cer (Table 2). For
C2-ceramide [4] the additional potency was attributed to an enhanced
ability to incorporate into the mitochondrial membrane. That is notTable 3
Extent of delivery of ceramide and its analogs tomitochondrialmembranes. The indicated
amount of lipid was added to amitochondrial suspension (160 μg protein). The percent of
the added lipid that incorporated into mitochondria is shown as mean±S.E. of 4 trials or
the values of individual trials. Column 4 shows the extent of analog insertion when added
with equal amounts of C16-Cer. The insertion of C16-Cer was not affected by the presence
of the analog. Column 5 is the t-test probability value obtainedwhen comparing results in
column 3 and 4.
Compound nmoles
added
% incorporation % incorporation in the
presence of C16-Cer
P value
D-C16-Cer 56 1.04±0.23
L-C16-Cer {S1} 56 0.41±0.06
C10-Cer {L1} 66 0.95±0.07 2.45±0.34 0.01
Phytoceramide {T2} 54 4.78±0.80 1.64±0.36 0.004
N-Me-C16-Cer {A3} 54 0.74, 0.85
1-O-Me-C16-Cer {H1} 54 1.00, 1.25
3-O-Me-C16-Cer {H2} 54 0.35, 0.95
15E-C16-Cer {T1} 56 0.23, 0.42the case for C10-ceramide {L1} (Table 2, column 5) as the perme-
abilization was increased 6 fold despite no difference in the degree
of incorporation into the MOM. Increasing the effective bulk of the
hydrocarbon chain by using ﬂuorescently labeled C6-NBD-ceramide
{L4}, or C18:1-Cer {L6} with a cis double bond in the middle of the
acyl chain, inhibited cytochrome oxidase activity. After correction
for the inhibition, channel formation by C18:1-Cer {L6} was indistin-
guishable from that of C16-Cer (Table 2).
Major alterations in ceramide's trans double bond were also well
tolerated (Tables 2 and 5). Some of these were analogs of C8-ceramide.
Under identical treatments, C8-Cer {L3} permeabilized the MOM to
cytochrome c 36% of the maximal permeabilization, whereas the
cis isomer {T6} resulted in a 61% of maximal permeabilization
(Table 5). An analog with an extra double bond (6E) in conjugation
with the ﬁrst ({T5}) permeabilized the outer membrane to the
same extent as the cis isomer {T6}. Moving the 4E double bond
to a position between the two hydroxyl groups by putting it at
the C3 position and moving the C3-hydroxyl group to the C5 position
{T7} did not prevent MOM permeabilization. Similar results were
obtained with analogs of C16-Cer. C16-phytoceramide {T2}, where the
4E-double bond is replaced by a C4-hydroxyl group, had a 2-fold higher
ability to permeabilize theMOM as compared to C16-Cer but this can be
more than accounted for by an enhanced ability to insert into the MOM
(Table 3). Replacing the 4E-double bond by a C4,C5-triple bond {T3}
also did not signiﬁcantly affect the ability of the molecule to permeabi-
lize theMOM.Moving the double bond farther down the chain {T1} to a
position that does not form an allylic system results in an enhanced
MOM permeabilization, despite a substantial reduction in its ability to
insert into mitochondria. Hence the location, conformation, and degree
of unsaturation do not have signiﬁcant effects on channel-forming
ability.
The amide linkage in ceramide is proposed to have similar orga-
nizing effects as the amide linkages in proteins [35]. The hydrogen-
bonding ability of this linkage was proposed to organize ceramide
monomers into columns. We found that increasing the hydrogen-
bonding ability of this region by introducing a “urea” linkage {A4}
resulted in an enhanced ability to permeabilize the MOM (Table 2).
Moreover, reducing the hydrogen-bonding capacity by using C8-
and C16-ceramines {A1, A2}, which differ from ceramide by having
an amino instead of an amide group, eliminated the molecule's ability
to permeabilize MOM to proteins. Since both of these ceramines
strongly inhibit cytochrome oxidase activity, release of adenylate ki-
nase from the mitochondrial intermembrane space was measured.
The ceramines caused no signiﬁcant release of adenylate kinase. For
C16-ceramine, kinase release was -0.6±7% for the highest dose tested
(8 nmol/μg mitochondrial protein). C8-ceramine was much more ef-
fective at releasing carboxyﬂuorescein from liposomes than C8-Cer
(Table 4) showing that it readily forms channels but these are very
small. Methylation of the amide nitrogen, affording N-methyl-C16-Cer
{A3}, drastically reduced but did not completely eliminate the ability
of the molecule to permeabilize the MOM to cytochrome c (Table 2).
The partitioning of {A3} into mitochondria was slightly reduced, how-
ever the reduced insertion into the membrane of this analog could not
account for the extent of its loss of function.
The ability of {A3} to form channels, even at a much reduced po-
tency raises a severe problem with the working model of the cer-
amide channel where the hydrogen bonding from the amide
nitrogen is essential to the overall structure. In the model, the
amide nitrogen of one ceramide molecule forms a hydrogen bond
with the carbonyl group of another to form ceramide columns. Meth-
ylation of the amide nitrogen as in {A3} would effectively prevent
such interactions. However, in molecular dynamic simulations per-
formed by Andriy Anishkin, whereas the working model of the
ceramide channel is the predominant form arising from such simula-
tions, other, minor forms were also detected. In some of these the car-
bonyl oxygen is not hydrogen bonding with the amide hydrogen of
Table 4
Comparison of channel-forming activity in mitochondria and liposomes. Liposomes
and mitochondria were treated with ceramide analogs to assess the latter's ability to
permeabilize membranes. For the liposomes (column 3) the % release of contents
was performed at 2 different doses: 87 and 147 nmol per 2.5 mL of liposome suspension.
For the MOM permeabilization (column 4) results are expressed as a % permeabilization
achieved by hypotonic shock. The dose used was 0.19 nmol/μg protein. Measurements
of adenylate kinase release (column 5) are expressed as percent of the kinase activity
released following treatment with 0.25 nmol/μg protein.
Compound Code Liposome
% release
MOM
% perm.
Adenylate kinase
% release
(2S,3R,4E) C8-ceramide L3 17±2
22±3
36±4 24±2
(2S,3R,4E) C8-ceraminea A2 100 N/D none
(2S,3R,4E) C2-OCH3-C8-ceramide A5 18±2
24±3
18±3 18±2
(2S,3R,4E,6E)C8-ceramide {diene} T5 32±3
40±3
62±5 42±4
(2S,3R,4Z) C8-ceramide
{cis analog}
T6 37±3
47±4
61±6 39±7
(2S,5R,3E) C8-ceramide T7 36±3
46±4
76±6 43±6
a Release from liposomeswas complete with as little as 15 nmol per 2.5 mL of liposome
suspension. MOM permeabilization could not be done (N/D) because of strong inhibition
of cytochrome oxidase.
Fig. 5. Cooperativity between analogs and C16-Cer. For an individual addition, a total
of 40 nmol was used. For combined additions (both), 20 nmol of each was used. The
average bar (avg) shows the average of the results obtained with each lipid alone.
The statistics are shown in Table 5. The individual and combined additions for each analog
were performedwith the same batch of mitochondria under the same conditions to avoid
the variability in sensitivity to ceramide found among mitochondrial preparations.
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through a water bridge (e.g. Fig. 3S). Thus it may be possible for
{A3} to form a similar structure.
The C1 and C3 hydroxyl groups have been proposed to stabilize
channel structure via hydrogen bonds with the corresponding func-
tional groups on adjacent ceramide molecules. Analogs of these func-
tional groups were utilized to determine the contribution of these
groups to the channel structure. O-Methylation of the C1-hydroxyl
group {H1} was chosen because the methyl group should prevent
this hydroxyl group from donating a hydrogen bond. The methylation
of the C1 hydroxyl resulted in an almost complete loss of any stable
MOM permeabilization despite no change in ability to insert into mi-
tochondria (Table 4). When the ability of {H1} to release adenylate ki-
nase was tested, it was almost double that observed with C16-Cer
indicating that twice as many mitochondria were permeabilized,
if only transiently, by {H1}. When reconstituted into planar mem-
branes, {H1} produced conductances that were transient (vide
infra) as opposed to the growing conductances observed with C16-
Cer (Fig. 8c). These were similar to those published for sphingosine
[36] except that these are large enough to allow the release of adeny-
late kinase (Fig. 4).
Unlike {H1},methylation at the C3-hydroxyl {H2} produced func-
tional properties very similar to those of C16-Cer (Table 2). Both the
cytochrome c oxidation assay and the adenylate kinase release assay
produced results indistinguishable from those of C16-Cer. The impor-
tance of the location of the C3-hydroxyl group and the stereochemis-
try of the adjacent chiral center were tested by relocating the
hydroxyl to the C5 position {T7} and by changing conﬁguration
from (2S,3R)-C16-Cer to (2S,3S)-C16-Cer {S2}, respectively. Neither
of these alterations had a large effect on the ability of these molecules
to permeabilize MOMs of isolated mitochondria (Table 2). Thus the
location and orientation of the C3-hydroxyl can be changed with min-
imal consequences. By sharp contrast, converting the (2S,3R)-C16-Cer
to (2R,3S)-C16-Cer {S1} (i.e. an additional change in the chirality at
C2) greatly reduced its ability to permeabilize MOMs, consistent
with the importance of the C1-hydroxyl group (Table 2). Unlike
the results with {H1}, {S1} was unable to permeabilize the MOM or
release adenylate kinase at 1 nmol/μg protein and produced only
16% of the permeabilization of C16-Cer at 3 nmol/μg protein. The
amount of insertion was reduced by a little over half but not enough
to account for the large reduction in ability to permeabilize the MOM.
Thus, the stereochemistry of ceramide that limits the possible andpreferred positions of its polar groups [35], can also inﬂuence the pro-
pensity for channel formation in the MOM.
3.2. Interactions between D-e-C16-ceramide and its analogs
Isolated mitochondria were treated with either C16-Cer alone or
the analog alone, or an equimolar mixture of C16-Cer and the analog
at half the dose. Thus, the total amount of sphingolipid added was
kept constant. The ability of each of the three treatments to permea-
bilize the MOM to cytochrome c was measured. Examples of the
results are shown in Fig. 5. For {A4} and {L2} the simultaneous pres-
ence of both lipids (designated as both) yielded a higher rate of cyto-
chrome c oxidation (and therefore a higher permeability) than the
average of the individual treatments (avg), thus indicating synergy.
The converse was true for {T4}, indicating antagonism. For {S2}
there was no signiﬁcant difference, indicating neutrality or no coop-
erativity. Depending on the experimental set, 40 nmol or 60 nmol of
lipids were utilized (as indicated in Table 5). The permeability result-
ing from the combined treatment (“combined effect” in Table 5) was
compared to the “expected average” which is the average of the
permeabilities observed with the individual sphingolipid treatments.
The ratio is reported in Table 5 along with the P values of statistical
signiﬁcance and the interpretation of the results. Ratios signiﬁcantly
Table 5
Cooperativity between C16-ceramide and its analogs. The analog was mixed in equimolar quantities with C16-Cer and the permeabilization of the MOM was compared to the av-
erage permeabilization observed with equal total amounts of either C16-Cer or the analog alone. At least 3 experiments were performed for each condition and P values for the
t-tests are listed. Using 95% conﬁdence, ratios signiﬁcantly greater than 1 are labeled synergistic; signiﬁcantly less than 1, antagonistic; not signiﬁcantly different, neutral.
Compound Code Combined effect expected average P value Nature of interaction
(2R,3S,4E) C16-ceramide S1 0.33 0.0005 Antagonistic
(2S,3S,4E) C16-ceramide S2 1a 0.36 Neutral
(2S,3R,4E) N-methyl-C16-ceramide A3 0.21 0.003 Antagonistic
(2S,3R,4E) C16-urea-ceramide A4 1.5a 0.015 Synergistic
(2S,3R,4E) 3-O-methyl-C16-ceramide H2 1.0 0.25 Neutral
(2S)-3-keto-C16-dh-ceramide H3 1.0 0.41 Neutral
(2S,3R,15E) C16-dh-ceramide T1 1.3 0.15 Neutral
(2S,3R,4R) C16-phytoceramide T2 0.52a 0.009 Antagonistic
(2S,3R) C16-4,5-tb-ceramide T3 0.95a 0.33 Neutral
(2S,3R,4E) C16-(4,5-allene)-ceramide T4 1.3 0.06 Neutral
(2S,3R,4E) C10-ceramide L1 1.5a 0.04 Synergistic
(2S,3R,4E) 13C/C16-ceramide L2 1.4a 0.02 Synergistic
N-palmitoyl-serinol L5 1.4 0.002 Synergistic
a The increase in MOMP resulting from the addition of a total of 3.6 nmol/μg protein of an equimolar mixture of C16-Cer and the speciﬁed analog was compared to 3.6 nmol/μg
protein of either C16-Cer or the analog alone. In the other experiments, 5.6 nmol/μg protein were used.
Fig. 6. Correlation betweendegree of cooperativity and ability of an analog to permeabilize
the MOM. Relative cooperativity is from column 3 of Table 5. The permeability relative to
C16-Cer is from Table 2 column 3 after dividing by 100 and taking the log.
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antagonism.
A subtle change, such as the replacement of the 4E double bond of
ceramide with a C4,C5-triple bond {T3}, resulted in a neutral effect
when combined with C16-Cer (Table 5). Experiments with the diaste-
reomer {S2} (2S,3S as opposed to 2S,3R for C16-Cer) were also consis-
tent with simple neutrality (Fig. 5 and Table 5).
Treating mitochondria with a mixture of C16-Cer and the shorter
chain analog, 13C/C16:0 {L2} resulted in a permeabilization that was
greater than the average of treatments with individual compounds
(Fig. 5). Similar results were obtained with other short-chain analogs
{L1, L5} (Table 5) and with urea-ceramide {A4}.
Mitochondria treated with an equimolar mixture of ceramide and
phytoceramide {T2} achieved a much reduced level of perme-
abilization than expected from averaging the individual treatments
(Fig. 5, Table 5). This inhibition was also found between phytocera-
mide {T2} and L-e-C16-Cer {S1} (data not shown). A similar antago-
nistic interaction was found between C16-Cer and either N-methyl-
C16–Cer {A3} or the enantiomer, (2R,3S) {S1}.
The type and degree of cooperativity correlates with the channel-
forming ability of the analog. A plot of the channel-forming potency
relative to that of C16-Cer versus the cooperativity ratio from
Table 5 shows the strong correlation (Fig. 6). The upper right quad-
rant contains data from the analogs showing synergy and higher pro-
pensity for channel formation whereas the lower right quadrant
contains data from those displaying antagonism and lower channel-
forming propensity. Analogs showing no cooperativity and essentially
similar channel-forming propensity to C16-Cer tend to cluster at the
“origin”. The other two quadrants are essentially vacant.
The permeabilization of the MOM following the dispersal of cer-
amide or an analog must involve at least two processes: insertion
and self-assembly. The cooperativity could take place at one or both
of these. The inﬂuence of combined delivery on the insertion of the
sphingolipids was assessed for one analog showing synergy {L1}
and one showing antagonism {T2} (Table 3). The presence of C16-
Cer inﬂuenced the ability of the analogs to insert into the MOM in
harmony with the observed cooperativity. The amount of {T2} that
inserted when combined with C16-Cer was one third of that measured
following its individual addition whereas the insertion of {L1} dou-
bled. The insertion of C16-Cer was not signiﬁcantly affected by the
presence of the analog.
The antagonism observed in mitochondrial experiments was also
evident in experiments with liposomes, showing a direct interaction
between these lipids. Premixing C16-Cer and C16-phytoceramide
{T2} resulted in a much smaller permeabilization of liposome mem-
branes than phytoceramide {T2} alone (Fig. 7).3.3. Channel formation in phospholipid membranes
To directly observe channel formation by ceramide analogs and to
gain insight into their stability and dynamics, experiments were per-
formed in deﬁned systems consisting of phospholipid membranes:
planar membranes and liposomes. In planar membranes, channel for-
mation was monitored as changes in conductance to K+ and Cl- ions.
In liposomes, the release of carboxyﬂuorescein and the quenching
agent, DPX, was used to assess the permeabilization of single-walled
liposomes by the analogs. In both of these experimental systems,
the analogs that were able to permeabilize the MOM were also able
to permeabilize phospholipid membranes that were free of proteins,
demonstrating that the analogs form channels rather than inducing
MOM proteins to form channels.
Most of the analogs that could permeabilize the MOM produced
conductances in planar membranes with similar characteristics to
those of C16-Cer. Examples for phytoceramide {T2} and urea-
ceramide {A4} are shown in Fig. 5. Channel formation occurred after
a lag phase and usually required a few separate additions. Fig. 8A
shows how a sustained conductance developed after a ﬁnal addition
Fig. 7. Permeabilization of liposomes by C16-Cer, C16-phytoceramide {T2}, or the two
together.
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until it reached a plateau. Sometimes the increase was rapid, reaching
a high conductance (Fig. 8B). At the reduced gain required to observe
the total conductance the increase appears to be very smooth.Fig. 8. Electrophysiological recording of conductances formed by ceramide analogs in planar
amounts of the analog were added at intervals (for a total of 4.6 nanomoles) with the last sh
disassembly by the addition of LaCl3. Channel formation followed the addition of 0.46 nmo
dition of 1 nmol of ceramide methylated at the C1-hydroxyl {H1}. The bursts shown were ob
A total of 25 nmol of C18:1 was added at intervals and similar patterns of channel growth and
clamped at 10 mV.Addition of La+3 resulted in channel disassembly after a variable
delay (Fig. 8B), which is similar to the effect of La+3 on a C16-cer-
amide channels as previously reported [10]. The variable delay is
characteristic of a stochastic process [10] and is also consistent with
the formation of a single channel that enlarges in size. Most of the an-
alogs appear to form a single large channel in the planar membrane
(data not shown), as was demonstrated for ceramide [10].
Marked exceptions were the behaviors of the conductances pro-
duced by 1-O-methyl-C16-ceramide {H1}, N-methyl-C16-ceramide
{A3} and C18:1-Cer {L6}. With these compounds, the conductance
rose rapidly but was transient, declining and returning to the baseline
shortly thereafter. This behavior was often observed multiple times in
the same membrane. Only occasionally would a prolonged conduc-
tance form. The analog with the shortest conductance bursts was
{H1} (Fig. 8C). The ﬁgure shows samples of conductance burst
recorded within a 40 min period of activity. {L6} was at the other
end of the spectrum, producing greater conductances but these also
tended to decay (Fig. 8D). The addition of more sample produced a
second transient conductance. {A3} was intermediate between
these (data not shown). The behavior of these analogs is consistent
with a less stable structure and in agreement with the observations
made with isolated mitochondria. {H1} produced virtually no perme-
ability; {A3} had a much diminished permeabilizing ability (21% of
that induced by C16-cer, Table 2); {L6} produced an effective perme-
abilization similar to C16-Cer. Clearly the channel dynamics are not
detectable in mitochondrial experiments and only the average per-
meability to cytochrome c is assessed.phospholipid membranes. A. The formation of a channel by urea ceramide {A4}. Equal
own in the ﬁgure. B. The formation of a C16-phytoceramide {T2} channel and its partial
l of C16-phytoceramide {T2}. C. Segments of conductance transients observed after ad-
served over a 40 min time period. D. Transient channels formed by {L6} C18:1-ceramide.
disassembly were seen after each addition. In all cases the transmembrane voltage was
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kinase release experiments produced results in agreement with mito-
chondrial permeability measurements (Table 4 and Fig. 4). {H1} and
the ceramines {A1} and {A2} were the exception. {A2} induced the
maximal release of liposomal contents, but did not facilitate the re-
lease of adenylate kinase from the mitochondrial intermembrane
space (Table 4). The fact that ceramine can permeabilize liposomes
to carboxyﬂuorescein, but did not permeabilize the MOM to adeny-
late kinase is consistent with its formation of small channels capable
of allowing small molecules to cross membranes, but not large
enough to allow the passage of proteins. These conductances resem-
ble those published for sphingosine [38]. Like {H1}, these conduc-
tances did not grow in size but returned to the baseline and were
likely the result of the formation of small pathways such as the toroi-
dal structures induced by amphipathic structures [12–14]. Unlike
{H1} the transient conductances did not become large enough to re-
lease adenylate kinase from mitochondria.
4. Discussion
The data presented show that the structure of ceramide can be al-
tered in a number of ways without losing the ability of the molecule
to permeabilize membranes in a manner that is consistent with self-
assembly into large channels capable of translocating proteins
through membranes. The mitochondrial and planar membrane ex-
periments suggest that many of the analogs form large, stable chan-
nels. The results indicate the relative importance of speciﬁc
structural features of ceramide for channel formation, namely the dif-
ferential importance of the hydroxyl groups, the role of the trans dou-
ble bond, and the importance of the stereochemistry.
4.1. Effect of chain length on ceramide channel formation
Physiologically, the length of the N-acyl chain of ceramide is clear-
ly very important [37,38]. For example, the ceramide synthases show
strong speciﬁcity for different acyl-CoA substrates [39–42]. Some
preferentially produce long-chain ceramides such as C16-Cer, while
others preferentially produce very long-chain ceramides such as
C24-Cer [40,41]. Many enzymes that metabolize ceramide do not rec-
ognize C2-Cer [43,44]. Yet, with regard to the ability to form channels,
the length of the N-acyl chain was found to be relatively unimportant
[1,3]. After compensating for the difference in delivery to the mito-
chondrial membranes, the potency of C16-Cer and C2-Cer were
found to be indistinguishable [4]. Here we tested analogs having
shorter N-acyl chains {L1, L3} and shorter sphingoid base backbones
{L2, L5}. The results indicate that these can also form permeability
pathways in membranes in a manner consistent with channels and
interact synergistically with ceramide. For {L1}, the synergy arises
from the ability of C16-Cer to aid in the insertion of {L1} into
mitochondria.
It is important to note that the minimal ceramide analog, N-
palmitoyl-serinol {L5}, functions very well with only one aliphatic
chain. Thus, one might ask why natural ceramides have such a large
amount of apolar mass. The simplest answer would be that the
extra bulk anchors the lipid in the membrane, limiting spontaneous,
uncatalyzed motion between membranes of different organelles.
4.2. Effect of modiﬁcations relating to the trans double bond and hydroxyl
groups
An important feature in the ceramide structure is the C4,C5-trans
double bond in the sphingoid base backbone [35,45]. For perme-
abilization of the MOM, many changes were well tolerated, namely
conversion of trans to cis, displacement of the double bond relative
to the adjacent hydroxyl, and replacement of the double bond by a
third hydroxyl. Thus, a variety of structures are capable ofpermeabilizing membranes in a manner consistent with the channels
formed by C16-ceramide.
The ability to form stable channels was lost by O-methylation of
the C1-hydroxyl group {H1}. It forms transient pores capable of
allowing adenylate kinase release but too short-lived to signiﬁcantly
increase the overall MOM permeability to proteins. The transient
conductances were evident in planar membrane experiments. By
contrast, O-methylation of the C3-hydroxyl group {H2} was well tol-
erated. Similar results with the C3-keto {H3} analog provide addition-
al evidence that C3-hydroxyl modiﬁcations are well tolerated. Further
evidence for a difference in the importance of these two hydroxyl
groups comes from results obtained with stereochemical isomers.
The diastereomer studied in which “3R” was changed to “3S” {S2}
showed no change in MOM permeabilizing properties despite a
change in orientation of the C3-hydroxyl. However, the enantiomer,
with the same change at the C3 position and an additional change
from “S” to “R” at the C2 position {S1}, was much weaker in its capac-
ity to permeabilize mitochondria. Thus the presence and orientation
of the free hydroxyl at C1 is critical to the stability of the channels, in-
dicating that this hydroxyl forms part of a highly organized structure.
4.3. Effect of changes at the amide linkage
The importance of the amide linkage as an organizing unit is sup-
ported by the ﬁnding that the conversion of an amide chain to an
amine-linked chain in ceramine {A1, A2} prevents the perme-
abilization of the MOM to proteins. If the ceramides are arranged in
the channel as proposed by the structural model [10,18], then the
conversion of the amide linkage to an amine would indeed destabilize
the structure by eliminating the hydrogen bonding that has been pro-
posed to be the basis for the columns that make up the channel. By
contrast, the greater hydrogen-bonding and ordering ability of a
urea linkage according to the structural model would be expected
to stabilize the channel, and indeed this analog {A4} forms channels
(Fig. 8A). The introduction of a methoxy group in the amide region
{A5} still allowed channel formation, indicating that the modiﬁcation
is tolerated.
N-methyl C16-Cer {A3} can still form channels, which is in appar-
ent contradiction to the structural model because the methyl group
that replaces the C3 hydroxyl cannot participate in hydrogen bond-
ing. While its ability to permeabilize the MOM is much reduced as
compared to C16-Cer and in planar membranes it forms unstable
channels, the ability to form channels at all seems to invalidate the
structural model of the ceramide channel. However, channel forma-
tion by {A3} is antagonistic with that of C16-Cer, indicating that struc-
tural incompatibilities were introduced by N-methylation. Molecular
modeling studies show that a channel can be formed with the carbon-
yl group hydrogen-bonding with the C1-hydroxyl group through a
water bridge as shown by the example structure in Fig. 3S. This struc-
ture is quite different from the working model of the ceramide chan-
nel [18].
4.4. Cooperativity between ceramide and analogs
Combined addition of C16-Cer and an analog showed cooperativity
in membrane permeabilization in certain cases: either synergy or an-
tagonism. The cooperativity correlates well with the ability of individ-
ual lipids to permeabilize the MOM. Surprisingly, the cooperativity
seems to involve the insertion into the MOM. Insertion may be cata-
lyzed by structures formed by sphingolipids in the membrane. Per-
haps ceramide forms phases or domains in the membrane that
could engage or exclude other analogs depending on the compatibil-
ity or incompatibility of the molecular structures (i.e. their ability to
bind to each other). Organized structures composed of many sphin-
golipids would require that each component ﬁt well sterically and
in bonding interactions. Thus very similar structures would be
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poorly compatible structures would show antagonism. Without
structural information it will be difﬁcult to understand the molecular
basis for the cooperativity.
5. Conclusions
The results of previously published work on ceramide channels
strongly suggests that these channels have a highly organized struc-
ture, one in which an altered conﬁguration of the polar lipid head re-
gion would disrupt the structure. The results presented here identify
key functional groups important for ceramide channel formation and
structural aspects where changes are tolerated. The C1-hydroxyl is in-
dispensable for channel stability whereas C3-hydroxyl is not critical
for channel formation. It is interesting that further elaborations of
ceramide in cells involve additions to the C1-hydroxyl rather than
the C3-hydroxyl, thus interfering with the propensity to form chan-
nels. The amide linkage is also highly important for channel stability.
Reducing the length of the hydrocarbon chains favors channel forma-
tion and indeed a single chain is sufﬁcient. The allylic system is not
necessary and the trans double bond does not seem important to
the ability to form channels. The sensitivity of channel stability to
the stereochemistry at C2 further supports the notion of ceramide
channels being highly-organized structures.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.bbamem.2012.02.010.
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